Help-Medical.Net

Acceleron Pharma, Inc., a biopharmaceutical group developing untried therapeutics that soften the spread of cells and tissues including muscle, bone, corpulence, red blood cells and the vasculature, today announced groundwork results from a Condition 1b mug up to assess the cover, tolerability and pharmacodynamic (PD) job of ACE-031 following multiple ascending doses in hale and hearty postmenopausal volunteers. ACE-031 is an investigational Read the rest of this entry »

Titan Pharmaceuticals, Inc. (OTC Account Surface: TTNP) today announced that details from its time past completed and announced Wind up 3 randomized, placebo-controlled clinical adversity of Probuphine were published in the Minutes of the American Medical Federation (JAMA).  The article highlights figures from the 163-patient tribulation, which showed that patients receiving Titan’s Probuphine root had significantly less prohibit opioid run Read the rest of this entry »

Prosensa, the Dutch biopharmaceutical body focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a upshot of achieving a information milestone in its Facet IIa honest hallmark development enquiry of GSK2402968 (PRO051), being developed to usage of Duchenne Husky Dystrophy (DMD) beneath its covenant with GSK. The milestone payment was based upon completion of a remunerative Read the rest of this entry »

Outset Pharmaceuticals, Inc. (Nasdaq:THLD) today announced interim results from an running Usher in 1/2 clinical distress in diversified true tumors interrelated to its hypoxia-activated prodrug, TH-302. The results were presented at the European Institute allowing for regarding Medical Oncology (ESMO) Annual Confluence being held in Milan, Italy.

Today’s display focused on possibly man clinical enquiry, the 402 burr under the saddle. Read the rest of this entry »

Ocular Therapeutix, Inc. announced today the finishing-off of a top Standard of Regulation clinical lucubrate with their best-seller continued treat parturition moxifloxacin punctum promotion.

The ponder was a single-site, single-armed, single-dose work in which ten patients received the punctum block the moment that following cataract surgery and were evaluated throughout a 10-day time. Select upshot measures were advert retention and Read the rest of this entry »

Sunshine Biopharma, Inc. (OTCBB: SBFM) a advancement place pharmaceutical flock focused on the investigating, situation and commercialization of drugs in requital for the treatment of miscellaneous forms of cancer, today announced that it issued a the humanities to its shareholders advising that it had filed in the service of blatant custody worldwide and expects to infiltrate Period I clinical trials due to the fact that its assets analgesic, Read the rest of this entry »

Attendees at next week’s European Way of life of Medical Oncology (ESMO) union in Milan commitment be presented with top-line Form III Clinical Trials statistics on Abiraterone in the treatment of castration-resistant prostate cancer. This uncharted soporific is the latest breakthrough in the course of the treatment of advanced cases and is the first-in-class intracrine androgen opponent for the sake of patients whose cancer has stopped responding Read the rest of this entry »

A vaccine that turns the protected methodology against cognition tumor cells behaviour a genetic varying that drives the most quarrelsome formulate of glioblastoma multiforme improved survival of patients in a facet II clinical bane, researchers at Duke University and The University of Texas MD Anderson Cancer Center reported today in the Annual of Clinical Oncology.

Eighteen newly diagnosed patients who were vaccinated after undergoing Read the rest of this entry »

Vivaglobin® (subcutaneous immunoglobulin [IgG]) (SCIg) is an personal property and strongbox original psychotherapy in the service of treatment-naive patients with drill immunodeficiency (PI) and may presentation an pulling possibility to intravenous IgG (IVIg) remedy in the newly diagnosed, according to evidence presented today at the XIVth Confluence of the European Institute respecting Immunodeficiencies. The workroom ground that IgG replacement Read the rest of this entry »

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has completed a pre-NDA assessment championing Lymphoseek® with the U.S. Bread and Pharmaceutical Delivery (FDA). As a conclusion of the pre-NDA assessment, FDA has requested that materials from both the completed NEO3-05 turn over and the NEO3-09 studio currently in in the works be included in the Company’s Read the rest of this entry »